Top 15 Long-Lasting Protection from Malaria Injection in Nigeria

Malaria, a life-threatening disease transmitted through mosquito bites, continues to pose a significant health challenge in Nigeria. With over 200 million cases reported annually, Nigeria bears the highest burden of malaria worldwide. In recent years, efforts to combat this disease have focused on developing long-lasting protection through malaria injections. In this article, we will explore the top 15 malaria injections available in Nigeria that provide extended protection against this debilitating illness.InformationGuideNigeria

Read Also: 15 Best Drugs for Typhoid and Malaria in Nigeria

Top 15 Long-Lasting Protection from Malaria Injection in Nigeria Are:

1. RTS,S/AS01 (Mosquirix):

Developed by GlaxoSmithKline, RTS,S/AS01 is the first and only licensed malaria vaccine to date. It provides partial protection against Plasmodium falciparum, the most prevalent malaria parasite in Nigeria.

2. PfSPZ Vaccine:

The PfSPZ vaccine, developed by Sanaria, uses whole, live Plasmodium falciparum sporozoites to stimulate an immune response. Initial trials have shown promising results in providing long-lasting protection.

Read Also: 15 Best Malaria Tablets In Nigeria

3. AMA1-C1/Alhydrogel:

AMA1-C1/Alhydrogel is a recombinant protein-based vaccine developed by the Walter Reed Army Institute of Research. It targets the Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and has shown potential in clinical trials.

4. MSP3-LSP:

The MSP3-LSP vaccine, developed by the Centre for Infectious Disease Research in Seattle, focuses on the Merozoite Surface Protein 3 (MSP3). It has demonstrated efficacy in preclinical and early-phase trials.

5. Combination Vaccines:

Several malaria vaccine candidates employ a combination of antigens to enhance protection. Examples include AMA1 and MSP1, RH5 and MSP2, and combinations of CSP, AMA1, MSP1, and MSP2. These combination vaccines aim to target multiple stages of the malaria parasite’s life cycle.

6. ChAd63-MVA ME-TRAP:

This vaccine candidate, developed by the University of Oxford, utilizes a viral vector to deliver multiple malaria antigens. It has shown encouraging results in early-phase trials and offers the potential for long-lasting protection.15 Best Tubular Batteries in Nigeria

Read Also: 5 ways to prevent malaria this year

7. PfSEA-1:

The PfSEA-1 vaccine, developed by the National Institute of Allergy and Infectious Diseases, targets a protein essential for Plasmodium falciparum survival. Initial studies indicate promising immune responses and the potential for extended protection.200 Romantic Messages

8. Pfs25:

Pfs25, a transmission-blocking vaccine, aims to interrupt the transmission of malaria parasites from humans to mosquitoes. Early-phase trials have demonstrated the potential of this vaccine to provide long-term protection.

9. PvRBSA:

Developed by the PATH Malaria Vaccine Initiative, PvRBSA focuses on a Plasmodium vivax protein. While it primarily targets P. vivax malaria, it shows potential as a component of combination vaccines for broader protection.NYSC Portal

10. R21:

The R21 vaccine, developed by the Jenner Institute and the University of Oxford, combines a novel adjuvant with the circumsporozoite protein (CSP) antigen. It has shown high efficacy in early-phase trials and offers hope for durable protection.105 Good Morning Messages

Read Also: Top 15 Widely Used Malaria Vaccine in Africa

11. PvDBP:

The PvDBP vaccine, targeting a protein involved in Plasmodium vivax’s invasion of red blood cells, is in advanced stages of development. Preliminary results show potential for long-lasting protection against P. vivax malaria.

12. PfCelTOS:

The PfCelTOS vaccine, developed by the University of California, San Diego, focuses on a conserved protein across Plasmodium species. Early-stage studies suggest it may induce robust and long-term immune responses.

13. RH5.1:

RH5.1, a vaccine candidate developed by the Jenner Institute, targets a protein involved in the invasion of red blood cells by Plasmodium falciparum. It has shown promise in preclinical studies.JAMB Portal

14. Combination of Subunit Vaccines:

Combining subunit vaccines targeting different stages of the malaria parasite’s life cycle may enhance protection. For example, combining CSP, MSP1, AMA1, and MSP2 has shown improved immune responses and prolonged protection in preclinical studies.15 Best Salad Cream Brands in Nigeria

15. Protein Degrade:

Protein Degrade vaccines aim to elicit antibodies that target specific proteins essential for parasite survival. Early research suggests this approach could lead to long-lasting protection against malaria.

Read Also: Top 15 Affordable Malaria Vaccine in Nigeria

Conclusion:

The fight against malaria in Nigeria requires innovative solutions, and the development of long-lasting protection through malaria injections is a promising avenue. The top 15 malaria injections discussed in this article offer various strategies to combat this disease, including targeting specific parasite proteins, combination vaccines, and transmission-blocking approaches. Continued research and investment in these vaccines are crucial to achieving sustained protection against malaria and reducing its devastating impact in Nigeria. With time, these advancements hold the potential to significantly reduce the burden of malaria and improve the overall health and well-being of the Nigerian population.

Check JAMB Result
Check and Confirm: How much is Dollar to Naira

📢 We are hiring writers!